Doctors Without Borders VS Johnson and Johnson Who Will Not Donate Licenses for HIV/AIDS Drugs as Others Have
Johnson and Johnson refuses to join the Medicines Patent Pool as others…
ImmunoGenetix Discovers a Safer Approach To HIV Treatment
James Laufenberg, CEO of ImmunoGenetix was interviewed by OneMedRadio where he discussed…
NanoViricides Reports Positive Anti-viral Effect of HIV Drug
NanoViricides (OTCBB:NNVC) announced Monday that its anti-HIV drug candidate, HIVCide, achieved a…